Recombinant TSR1 of ADAMTS5 Suppresses Melanoma Growth in Mice via an Anti-angiogenic Mechanism
Inhibiting tumor angiogenesis is a well-established approach for anticancer therapeutic development. A Disintegrin-like and Metalloproteinase with ThromboSpondin Motifs 5 (ADAMTS5) is a secreted matrix metalloproteinase in the ADAMTS family that also functions as an anti-angiogenic/anti-tumorigenic...
Main Authors: | Bhuvanasundar Renganathan, Vinoth Durairaj, Dogan Can Kirman, Paa Kow A. Esubonteng, Swee Kim Ang, Ruowen Ge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/10/6/192 |
Similar Items
-
Serum Level of ADAMTS4 and ADAMTS8 in Patients with Psoriatic Arthritis
by: Irmak Icen Taskin, et al.
Published: (2020-12-01) -
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Quintijn Bonnez, et al.
Published: (2023-09-01) -
Development of a fluorogenic ADAMTS-7 substrate
by: Salvatore Santamaria, et al.
Published: (2021-01-01) -
Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia
by: Daniel Gao, et al.
Published: (2023-07-01) -
Hybrid TSR–PSR Alternate Energy Harvesting Relay Network over Rician Fading Channels: Outage Probability and SER Analysis
by: Tan N. Nguyen, et al.
Published: (2018-11-01)